Ferroptosis-IN-19
Ferroptosis-IN-19 (compound C18) is a strong cellular ferroptosis inhibitor with an IC50 value of 0.097 μM. Ferroptosis-IN-19 shows high metabolic stability and favorable BBB permeability prediction. Ferroptosis-IN-19 has in vivo neuroprotection against ischemic brain injury in mice[1].
Product Specifications
CAS Number
3025114-13-7
UNSPSC
12352005
Target
Ferroptosis
Related Pathways
Apoptosis
Applications
Neuroscience-Neurodegeneration
Field of Research
Cardiovascular Disease
Purity
98.92
Smiles
ClC1=C(OC)C=CC(NC2=C(C3CCCCC3)N=C4N2C=CC=C4)=C1
Molecular Formula
C20H22ClN3O
Molecular Weight
355.86
References & Citations
[1]Jilei Wang, et al. Identification of imidazo[1,2-a]pyridine-3-amine as a novel drug-like scaffold for efficious ferroptosis inhibition in vivo. Eur J Med Chem. 2025 Jun 5:290:117516.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, stored under nitrogen)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog